News

Intercell buys Cytos’ MAbs technology for 15 million euros

07-05-2010

Austrian firm Intercell AG has signed an agreement with Switzerland-based Cytos Biotechnology to acquire…

Antibiotics and Infectious diseasesBiotechnologyCytos BiotechnologyIntercellLicensingPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top